Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MannKind Corp

+ Add to Watchlist

MNKD:US

4.1800 USD 0.1100 2.56%

As of 20:10:00 ET on 05/01/2015.

Snapshot for MannKind Corp (MNKD)

Open: 4.2900 Day's Range: 4.1400 - 4.3800 Volume: 5,470,532
Previous Close: 4.2900 52wk Range: 4.1400 - 11.4800 1-Yr Rtn: -34.17%

Stock Chart for MNKD

No chart data available.
  • MNKD:US 4.1800
  • 1D
  • 1M
  • 1Y
4.2900
Interactive MNKD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MNKD

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5100
Est. EPS (USD) (12/2015) -0.3400
Est. PEG Ratio -
Market Cap (M USD) 1,710.05
Shares Outstanding (M) 409.10
30 Day Average Volume 4,104,822
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MNKD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MNKD

MannKind Corporation is a biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Companys lead investigational product candidate is the Technosphere Insulin System.

Alfred E MannChairmanHakan S EdstromPresident/CEO
Matthew J Pfeffer "Matt"VP/CFO/Investor RelationsJuergen A MartensVP/COO
More Company Profile & Key Executives for MNKD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil